Representative Matters

Champignon Brands Completes $15 Million Bought Deal Private Placement

Aird & Berlis advised Champignon Brands Inc., a ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer, in connection with its $15 million bought deal private placement. The net proceeds of the offering are intended to be used for Champignon’s North American clinical expansion program and for general working capital purposes.

The Aird & Berlis team was led by Jeffrey Merk and included Melanie Cole and Russell Sanders (Capital Markets/M&A) and Francesco Gucciardo (Tax).